For In Vitro Diagnostic Testing Industry, Repeal a Mixed Bag
By a
"For the medical device and the in vitro diagnostics industry, which the healthcare market research covers, one of the most important policy priorities has been a complete repeal of the suspended medical device tax," said
The tax as part of the ACA is unpopular broadly in the device industry. The legislation put a 2.3% excise tax on sales (not simply profits) of medical devices, except certain devices sold at retail. If the
A concern for IVD companies and other healthcare suppliers would be the decline of healthcare utilization in
Testing is part of prevention, and this would be a concern for IVD companies. The fate of preventative care service provisions of the ACA, including the obligation of insurers to pay for USPSTF-recommended services without copay, is uncertain at this time. The inclusion of services has been a boon to certain in vitro diagnostic (IVD) markets and suppliers as higher patient volumes and more routine care boosted demand for select screening tests. The
However, Kalorama notes that the needs of the IVD industry extend beyond Obamacare repeal.
"
Keywords for this news article include: Medicaid, Health Policy, Kalorama Information.
Our reports deliver fact-based news of research and discoveries from around the world. Copyright 2017, NewsRx LLC
Azuga Teams Up with Allstate’s Signature Motor Club for Roadside Assistance
ACA reduced disparities in health care access, report shows
Advisor News
Annuity News
Health/Employee Benefits News
Life Insurance News